Mufg Americas Holdings Corp Organon & Co. Transaction History

Mufg Americas Holdings Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 01, 2022	SELL	$23.4 - $34.25 $3,018 - $4,418	-129 Reduced 97.73%	3 $0
Q3 2022 Oct 31, 2022	SELL	$23.4 - $34.25 $3,018 - $4,418	-129 Reduced 97.73%	3 $0
Q2 2022 Dec 01, 2022	SELL	$31.66 - $38.9 $63 - $77	-2 Reduced 1.49%	132 $4,000
Q2 2022 Aug 02, 2022	SELL	$31.66 - $38.9 $63 - $77	-2 Reduced 1.49%	132 $4,000
Q1 2022 Dec 01, 2022	SELL	$30.45 - $39.36 $1,400 - $1,810	-46 Reduced 25.56%	134 $5,000
Q1 2022 May 06, 2022	SELL	$30.45 - $39.36 $1,400 - $1,810	-46 Reduced 25.56%	134 $5,000
Q4 2021 Dec 01, 2022	SELL	$28.67 - $37.13 $8,830 - $11,436	-308 Reduced 63.11%	180 $5,000
Q4 2021 Feb 09, 2022	SELL	$28.67 - $37.13 $8,830 - $11,436	-308 Reduced 63.11%	180 $5,000
Q3 2021 Dec 01, 2022	SELL	$28.63 - $35.64 $377,887 - $470,412	-13,199 Reduced 96.43%	488 $16,000
Q3 2021 Nov 05, 2021	SELL	$28.63 - $35.64 $377,887 - $470,412	-13,199 Reduced 96.43%	488 $16,000
Q2 2021 Dec 01, 2022	BUY	$28.45 - $38.0 $389,309 - $519,992	13,684 Added 456133.34%	13,687 $414,000
Q2 2021 Aug 06, 2021	BUY	$28.45 - $38.0 $389,395 - $520,106	13,687 New	13,687 $414,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

Stay updated on Mufg Americas Holdings Corp with notifications on news.